Anchored Muscle cELls for IncontinencE

Informazioni relative al progetto

AMELIE

ID dell’accordo di sovvenzione: 874807

DOI

10.3030/874807

Data della firma CE 6 Maggio 2020

Data di avvio 1 Settembre 2020

Data di completamento 31 Agosto 2026

Finanziato da

• SOCIETAL CHALLENGES - Health, demographic change and well-being

Costo totale

€ 9 526 097,25

Contributo UE

€ 9 526 097,25

Coordinato da

UNIVERSITY COLLEGE LONDON
United Kingdom

CORDIS fornisce collegamenti ai risultati finali pubblici e alle pubblicazioni dei progetti ORIZZONTE.

I link ai risultati e alle pubblicazioni dei progetti del 7° PQ, così come i link ad alcuni tipi di risultati specifici come dataset e software, sono recuperati dinamicamente da .OpenAIRE .

Risultati finali

Websites, patent fillings, videos etc. (3)

Creation of AMELIE website

Devising a project specific website service provider to set up and maintain with intranet consortium members only access and internet public access domains with dedicated patient and public pages reporting AMELIEs research outcomes

Enhanced PPI Survey

Survey format agreed Survey disseminated Results collated and analysed

Trial Delivery Support

Protocol work/ agreement Steering Groups attendance PILS/public facing work

Pubblicazioni

Peer reviewed articles (6)

Cryopreservation of implantable human skeletal muscle-derived cell-microcarrier combinations for use in clinical regenerative medicine

Autori: Chara Simitzi, Juzheng Zhang, Rainer Marksteiner, Barry Fuller, Richard Day
Pubblicato in: Cytotherapy, 2025, ISSN 1465-3249
Editore: Taylor & Francis
DOI: 10.1016/j.jcyt.2025.09.005

Bioprocessing Considerations towards the Manufacturing of Therapeutic Skeletal and Smooth Muscle Cells

Autori: Franchi-Mendes, T.; Silva, M.; Cartaxo, A.L.; Fernandes-Platzgummer, A.; Cabral, J.M.S.; da Silva, C.L.
Pubblicato in: Bioengineering, 2023, ISSN 2306-5354
Editore: MDPI
DOI: 10.3390/bioengineering10091067

Developing a cell-microcarrier tissue engineered product for muscle repair using a bioreactor system

Autori: Ana Luísa Cartaxo, Ana Fernandes, Carlos Rodrigues, Ana M. Melo, Katja Tecklenburg, Eva Margreiter, Richard M Day, Cláudia L da Silva and Joaquim M S Cabral
Pubblicato in: Tissue Engineering Part C: Methods, 2023, ISSN 1937-3384
Editore: Mary Ann Liebert Inc.
DOI: 10.1089/ten.tec.2023.0122

CT‐Visible Microspheres Enable Whole‐Body In Vivo Tracking of Injectable Tissue Engineering Scaffolds

Autori: Annalisa Bettini, Peter Stephen Patrick, Richard M. Day, Daniel J. Stuckey
Pubblicato in: Advanced Healthcare Materials, Numero 13, 2024, ISSN 2192-2640
Editore: John Wiley and Sons Ltd
DOI: 10.1002/adhm.202303588

Cell Shape Characteristics of Human Skeletal Muscle Cells as a Predictor of Myogenic Competency: A New Paradigm Towards Precision Cell Therapy for Incontinence

Autori: Charlotte Desprez, Davide Danovi, Charles Knowles, Richard Day
Pubblicato in: Journal of Tissue Engineering, Numero Jan.-Dec. 2023, 2023, ISSN 2041-7314
Editore: SAGE Publishing
DOI: 10.1177/20417314221139794

Building rings with spheres: a cell therapy approach to incontinence

Autori: Martha Gilbert, Simona Čaputová, Delielena Poli, Manou Kooy, Georgia Sturt, Josephine Parker, Richard Day
Pubblicato in: Cell & Gene Therapy Insights, Numero 9(10), 2023, Pagina/e 1293–1306, ISSN 2059-7800
Editore: Bioinsights Publishing Ltd
DOI: 10.18609/cgti.2023.167